R

Active Director Director DIN 09364154
DIN 09364154 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Renu

Data last updated:

Renu is a Director at Parrymed Healthcare Private Limited (since 2021). The company operates in Chemicals. Parrymed Healthcare Private Limited reported revenue of ₹8.3 Lakh (FY 2025).

DIN 09364154
Primary Designation Director
Industry Chemicals
First Appointment 18 Oct 2021
Oldest Company Age 5 yrs
Largest company Parrymed Healthcare Private Limited · ₹8.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Parrymed Healthcare Private Limited U24230DL2021PTC388456
Director18 Oct 20212021₹8.3 Lakh (FY 2025)Active

Board colleagues of Renu

NameDINCompanyDesignation
Praveen Kumar Tripathi09364153Parrymed Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Parrymed Healthcare Private Limited
Premium access

Shareholding and investment profile for Renu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu

Renu currently holds 1 directorship: Parrymed Healthcare Private Limited (Director, since 18 Oct 2021, revenue ₹8.3 Lakh (FY 2025)).

Renu was first appointed on 18 Oct 2021 as Director at Parrymed Healthcare Private Limited.

The current boards of Renu's companies include Praveen Kumar Tripathi (Parrymed Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available